What are the Common Challenges in Pediatric Drug Development?
Several challenges are commonly encountered in the development of pediatric drugs:
1. Clinical Trials: Conducting clinical trials in children is more complex due to ethical concerns, recruitment difficulties, and the need for age-appropriate study designs. 2. Regulatory Hurdles: Regulatory requirements for pediatric formulations can be stringent, requiring extensive data on safety, efficacy, and appropriate dosing. 3. Market Demand: The market for pediatric drugs is smaller compared to adults, making it less financially attractive for pharmaceutical companies to invest in specialized pediatric formulations.
